GermFalcon Strikes a Deal with Honeywell to Sell, Produce Its Anti-Viral 'Drink Cart' For Cleaning Airplanes

GermFalcon Strikes a Deal with Honeywell to Sell, Produce Its Anti-Viral 'Drink Cart' For Cleaning Airplanes

Industrial conglomerate Honeywell International snapped up the rights to produce, advertise and sell Long Beach-based Dimer's anti-viral UV-C light machine, the GermFalcon, in a licensing partnership agreement announced on Wednesday.

Created by Elliot Kreitenberg and his father, orthopedic surgeon Arthur Kreitnberg, in their garage seven years ago, the GermFalcon can sanitize a midsize airplane cabin full of germs in about 10 minutes and is being billed as an antidote in the age of COVID-19.


The GermFalcon will be renamed the Honeywell UV Cabin System.

"This offering is a big win for our airline customers, which are seeking affordable ways to clean their cabins effectively and quickly between flights," said Mike Madsen, Honeywell Aerospace president and chief executive. "Honeywell is working on a range of solutions to help make passengers more comfortable about flying."

Courtesy of GermFalcon

Honeywell, a major supplier to Airbus and Boeing among others, is in discussions with several major airlines and service providers for the cabin system. The company has been hurt by the grounding of Boeing's 737 and further struck by plummeting airplane passenger traffic.

Honeywell is accepting orders and expects the first shipments in July. Pricing will vary, but Honeywell estimates that for midsize to large airlines with hundreds or more aircraft, the cost will break down to about $10 per use.

The North Carolina company has been bolstering their offerings of products aimed at making flying safer for passengers loathe to go in confined spaces where a virus might easily spread.

The size of a drink cart, Kreitenberg sees the GermFalcon as the antidote to the spread of viruses.

"Airlines play a direct role in the way that disease spreads around the world," Elliot Kreitenberg told dot.LA last month. "We see that here with coronavirus. It flew here on airplane."

Dimer is also continuing to further commercialize and deploy its germicidal UV technology platform known as UVHammer for healthcare. The UVHammer product will target public transportation, education, hospitality, buildings, theaters, arenas and small businesses alike. It's expected to be brought to market in July.

Subscribe to our newsletter to catch every headline.

Minutes into filling out my absentee ballot last week, I was momentarily distracted by my dog Seamus. A moment later, I realized in horror that I was filling in the wrong bubble — accidentally voting "no" on a ballot measure that I meant to vote "yes" on.

It was only a few ink marks, but it was noticeable enough. Trying to fix my mistake, I darkly and fully filled in the correct circle and then, as if testifying to an error on a check, put my initials next to the one I wanted.

Then I worried. As a reporter who has previously covered election security for years, I went on a mini-quest trying to understand how a small mistake can have larger repercussions.

As Los Angeles County's 5.6 million registered voters all receive ballots at home for the first time, I knew my experience could not be unique. But I wondered, would my vote count? Or would my entire ballot now be discarded?

Read more Show less

When the founders who lead the ten young startups selected for the 2020 Techstars LA class begin their three month accelerator program Monday, they won't be gathering in the Mid-Wilshire office and shaking hands as every other class has done. Like the rest of us, they will be working at home because of the coronavirus. Dinners, meetings, socializing, and mentoring sessions will all be online.

"A big part of the magic of the program is the relationships that are from proximity and from everyone working together in the same space and so what we're doing is we're endeavoring to create as much as that connection in the virtual world as possible," said Anna Barber, managing director of Techstars LA.

Read more Show less
RELATEDEDITOR'S PICKS

Trending